Coronavirus is changing its form day by day, due to which scientists and doctors have to make a lot of effort. The way the second wave has caused havoc after the first of Corona, another news that has come after that has worried everyone. According to a report, scientists have told that the delta variant, also known as B1.617.2, which caused havoc in the country in the second wave of the corona, has turned into a more dangerous variant than before. This changed variant is being called Delta Plus or AY.1. Scientists fear that even the monoclonal antibodies cocktail being given to corona patients will not have an effect on this variant.
What is Monoclonal Antibodies Cocktail?
Monoclonal Antibodies Cocktail is a drug used in the treatment of corona. However, it is treated only when the patient’s condition is at a very critical stage. This drug is manufactured jointly by the pharma company Cipla and Roche India. In India, it was approved in May for emergency use for the treatment of corona. The drug has received approval from the Central Drugs Standards Control Organization (CDSCO) for emergency use in the US and European Union countries.
Till June 7, 6 cases came to the fore
According to a report by the UK health organization Public Health England (PHE), 63 genomes of the delta variant have been revealed with the new K417N mutation. PHE came to know of Delta Plus during a routine check of changes in the Delta variant. According to this recent report on Kovid variants, 6 cases of delta plus variant of coronavirus were reported in India till June 7.
The frequency of this variant is low in India
Dr. Vinod Skaria of Delhi’s Institute of Genomics and Integrative Biology has said that the key concern about the K417N mutation is the evidence that it is resistant to the antibody cocktail. However, he also says that the frequency of K417N mutation is not very high in India.